Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 276

1.

Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice.

Manzini S, Pinna C, Busnelli M, Cinquanta P, Rigamonti E, Ganzetti GS, Dellera F, Sala A, Calabresi L, Franceschini G, Parolini C, Chiesa G.

Vascul Pharmacol. 2015 Aug 5. pii: S1537-1891(15)00182-2. doi: 10.1016/j.vph.2015.08.006. [Epub ahead of print]

2.

Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study.

Muiesan ML, Salvetti M, Paini A, Agabiti Rosei C, Rubagotti G, Negrinelli A, Gregorini G, Cancarini G, Calabresi L, Franceschini G, Obici L, Perlini S, Merlini G, Agabiti Rosei E.

Amyloid. 2015 Sep;22(3):187-93. doi: 10.3109/13506129.2015.1066771. Epub 2015 Jul 25.

PMID:
26193960
3.

Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome.

Gomaraschi M, Ossoli A, Adorni MP, Damonte E, Niesor E, Veglia F, Franceschini G, Benghozi R, Calabresi L.

Vascul Pharmacol. 2015 Jun 30. pii: S1537-1891(15)00145-7. doi: 10.1016/j.vph.2015.06.014. [Epub ahead of print]

PMID:
26133666
4.

Oxidized regenerated cellulose in breast surgery: experimental model.

Franceschini G, Visconti G, Sanchez AM, Di Leone A, Salgarello M, Masetti R.

J Surg Res. 2015 Sep;198(1):237-44. doi: 10.1016/j.jss.2015.05.012. Epub 2015 May 15.

PMID:
26055212
5.

Contralateral breast symmetrisation in immediate prosthetic breast reconstruction after unilateral nipple-sparing mastectomy: the tailored reduction/augmentation mammaplasty.

Salgarello M, Visconti G, Barone-Adesi L, Franceschini G, Masetti R.

Arch Plast Surg. 2015 May;42(3):302-8. doi: 10.5999/aps.2015.42.3.302. Epub 2015 May 14.

6.

Update on the surgical management of breast cancer.

Franceschini G, Sanchez AM, Di Leone A, Magno S, Moschella F, Accetta C, Natale M, Di Giorgio D, Scaldaferri A, D'Archi S, Scardina L, Masetti R.

Ann Ital Chir. 2015 Feb 20;86:89-99.

PMID:
25951853
7.

Update on the surgical management of breast cancer.

Franceschini G, Sanchez AM, Di Leone A, Magno S, Moschella F, Accetta C, Natale M, Di Giorgio D, Scaldaferri A, D'Archi S, Scardina L, Masetti R.

Ann Ital Chir. 2015 Feb 20;86. pii: S0003469X15023295. [Epub ahead of print]

PMID:
25951812
8.

AMAROS Study: Overall Survival in Breast Cancer Subtypes.

Orlandi A, Franceschini G, Astone A, Masetti R, Barone C.

Clin Oncol (R Coll Radiol). 2015 Aug;27(8):485-6. doi: 10.1016/j.clon.2015.04.002. Epub 2015 May 1. No abstract available.

PMID:
25936629
9.

Mammographic and Ultrasonographic Findings of Oxidized Regenerated Cellulose in Breast Cancer Surgery: A 5-Year Experience.

Giuliani M, Fubelli R, Patrolecco F, Rella R, Borelli C, Buccheri C, Di Giovanni SE, Belli P, Romani M, Rinaldi P, Bufi E, Franceschini G, Bonomo L.

Clin Breast Cancer. 2015 Mar 24. pii: S1526-8209(15)00072-5. doi: 10.1016/j.clbc.2015.03.008. [Epub ahead of print]

PMID:
25922282
10.

Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.

Bufi E, Belli P, Costantini M, Cipriani A, Di Matteo M, Bonatesta A, Franceschini G, Terribile D, Mulé A, Nardone L, Bonomo L.

Clin Breast Cancer. 2015 Feb 21. pii: S1526-8209(15)00030-0. doi: 10.1016/j.clbc.2015.02.002. [Epub ahead of print]

PMID:
25891905
11.

Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function.

Gomaraschi M, Adorni MP, Banach M, Bernini F, Franceschini G, Calabresi L.

Handb Exp Pharmacol. 2015;224:593-615. doi: 10.1007/978-3-319-09665-0_19. Review.

PMID:
25523003
12.

Diffusion magnetic resonance imaging in breast cancer characterisation: correlations between the apparent diffusion coefficient and major prognostic factors.

Belli P, Costantini M, Bufi E, Giardina GG, Rinaldi P, Franceschini G, Bonomo L.

Radiol Med. 2015 Mar;120(3):268-76. doi: 10.1007/s11547-014-0442-8. Epub 2014 Aug 6.

PMID:
25096888
13.

HDL and atherosclerosis: Insights from inherited HDL disorders.

Calabresi L, Gomaraschi M, Simonelli S, Bernini F, Franceschini G.

Biochim Biophys Acta. 2015 Jan;1851(1):13-8. doi: 10.1016/j.bbalip.2014.07.015. Epub 2014 Jul 25. Review.

PMID:
25068410
14.

The Breast Unit Update on advantages and the open issues.

Franceschini G, Di Leone A, Masetti R.

Ann Ital Chir. 2014 Sep-Oct;85(5):407-12.

PMID:
25047121
15.

Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.

Calabresi L, Simonelli S, Conca P, Busnach G, Cabibbe M, Gesualdo L, Gigante M, Penco S, Veglia F, Franceschini G.

J Intern Med. 2015 May;277(5):552-61. doi: 10.1111/joim.12290. Epub 2014 Aug 1.

PMID:
25039266
16.

Primary systemic treatment and concomitant low dose radiotherapy for breast cancer: final results of a prospective phase II study.

Nardone L, Diletto B, De Santis MC, D' Agostino GR, Belli P, Bufi E, Franceschini G, Mulé A, Sapino A, Terribile D, Valentini V.

Breast. 2014 Oct;23(5):597-602. doi: 10.1016/j.breast.2014.06.005. Epub 2014 Jul 4.

PMID:
24998453
17.

Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment.

Bufi E, Belli P, Di Matteo M, Terribile D, Franceschini G, Nardone L, Petrone G, Bonomo L.

Eur J Radiol. 2014 Sep;83(9):1631-8. doi: 10.1016/j.ejrad.2014.05.002. Epub 2014 May 16.

PMID:
24938669
18.

Oncoplastic breast surgery with oxidized regenerated cellulose: appraisals based on five-year experience.

Franceschini G, Visconti G, Masetti R.

Breast J. 2014 Jul-Aug;20(4):447-8. doi: 10.1111/tbj.12297. Epub 2014 May 26. No abstract available.

PMID:
24862499
19.

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.

Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration.

Lancet Diabetes Endocrinol. 2014 Aug;2(8):634-47. doi: 10.1016/S2213-8587(14)70102-0. Epub 2014 May 16.

20.

eNOS activation by HDL is impaired in genetic CETP deficiency.

Gomaraschi M, Ossoli A, Pozzi S, Nilsson P, Cefalù AB, Averna M, Kuivenhoven JA, Hovingh GK, Veglia F, Franceschini G, Calabresi L.

PLoS One. 2014 May 15;9(5):e95925. doi: 10.1371/journal.pone.0095925. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk